JaLCDOI | 10.18926/AMO/31976 |
---|---|
FullText URL | fulltext.pdf |
Author | Nagai, Atsushi| Tokuyama, Eijirou| Nanba, Yuzaburo| Tsutsui, Tetsuya| Kimata, Yoshihiro| Nakatsuka, Mikiya| Koshima, Isao| Saika, Takashi| Nasu, Yasutomo| Kumon, Hiromi| |
Abstract | <p>The first case of sex reassignment surgery (SRS) in our hospital was performed in January 2001; as of February, 2005, 4 cases of MTF-SRS had been performed. In the 2 most recent cases, we used penile and scrotal skin flaps to avoid complications. The depth and width of the new vagina was made to be adequate for sexual intercourse. Future attention should be focused on devising a surgical technique that will help prevent the complications of partial necrosis of the epidermal skin and wound dehiscence. Although ours is only an initial experience, we describe our surgical technique herein.</p> |
Keywords | gender identity disorder sex reassignment surgery male to female transsexual |
Amo Type | Article |
Published Date | 2005-10 |
Publication Title | Acta Medica Okayama |
Volume | volume59 |
Issue | issue5 |
Publisher | Okayama University Medical School |
Start Page | 231 |
End Page | 233 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | 英語 |
File Version | publisher |
Refereed | True |
PubMed ID | 16286961 |
Web of Science KeyUT | 000232835600008 |
JaLCDOI | 10.18926/AMO/31956 |
---|---|
FullText URL | fulltext.pdf |
Author | Nagai, Atsushi| Kusumi, Norihiro| Tsuboi, Hiromu| Ishii, Kazushi| Saika, Takashi| Nasu, Yasutomo| Kumon, Hiromi| |
Abstract | <p>We report on 64 patients who did not achieve erections adequate for satisfactory sexual intercourse from among a total of 243 patients who were prescribed PDE5 inhibitors for erectile dysfunction (ED). Intracavernous injection (ICI) of PGE was performed in this non-responder group. An ICI of 20 or 40 mcg of PGE1 in 1 ml saline was performed and the responses evaluated. Forty-nine out of 64 (77 percent ) cases responded to 20 mcg of PGE1. Forty mcg of PGE was injected into the 15 non-responding cases, and 9 patients responded favorably. The overall effective rate was 58/64 (91 percent ). No major adverse effects were observed.</p> |
Keywords | prostaglandin E1 intracavernous injection erectile dysfunction PDE5 inhibitors |
Amo Type | Short Communication |
Published Date | 2005-12 |
Publication Title | Acta Medica Okayama |
Volume | volume59 |
Issue | issue6 |
Publisher | Okayama University Medical School |
Start Page | 279 |
End Page | 280 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | 英語 |
File Version | publisher |
Refereed | True |
PubMed ID | 16418771 |
Web of Science KeyUT | 000234176600006 |
JaLCDOI | 10.18926/AMO/32875 |
---|---|
FullText URL | fulltext.pdf |
Author | Namba, Yuzaburo| Sugiyama, Narushi| Yamashita, Shuji| Hasegawa, Kenjiro| Kimata, Yoshihiro| Ishii, Kazushi| Nasu, Yasutomo| |
Abstract | <p>To date, many techniques have been reported for vaginoplasty in male-to-female trans-sexual (MTFTS) patients, such as the use of a rectum transfer, a penile-scrotal flap and a reversed penile flap. However, none of these procedures is without its disadvantages. We developed a newly kind of flap for vaginoplasty, the M-shaped perineo-scrotal flap (M-shaped flap), using skin from both sides of the scrotum, shorn of hair by preoperative laser treatment. We applied this new type of flap in 7 MTFTS patients between January 2006 and January 2007. None of the flaps developed necrosis, and the patients could engage in sexual activity within 3 months of the operation. The M-shaped flap has numerous advantages: it can be elevated safely while retaining good vascularity, it provides for the construction of a sufficient deep vagina without a skin graft, the size of the flap is not influenced entirely by the length of the penis, and it utilizes skin from both sides of the scrotal area, which is usually excised.</p> |
Keywords | vaginoplasty male-to-female transsexual perineo-scrotal flap |
Amo Type | Original Article |
Published Date | 2007-12 |
Publication Title | Acta Medica Okayama |
Volume | volume61 |
Issue | issue6 |
Publisher | Okayama University Medical School |
Start Page | 355 |
End Page | 360 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | 英語 |
File Version | publisher |
Refereed | True |
PubMed ID | 18183081 |
Web of Science KeyUT | 000251943800007 |
Author | Yokoyama, Teruhiko| Watanabe, Toyohiko| Saika, Takashi| Nasu, Yasutomo| Kumon, Hiromi| Miyaji, Yoshiyuki| Nagai, Atsushi| |
---|---|
Published Date | 2007-10-02 |
Publication Title | International Journal of Urology |
Volume | volume14 |
Issue | issue7 |
Content Type | Journal Article |
JaLCDOI | 10.18926/AMO/31964 |
---|---|
FullText URL | fulltext.pdf |
Author | Nagai, Atsushi| Nasu, Yasutomo| Watanabe, Masami| Kusumi, Norihiro| Tsuboi, Hiromu| Kumon, Hiromi| |
Abstract | <p>We investigated the usefulness of one-stage urethroplasty by the parameatal foreskin flap method (OUPF procedure), which is useful for repairing all types of hypospadias. Between June 1992 and March 2001, the OUPF procedure was performed on 18 patients with hypospadias: 10 patients with distal and 8 with proximal hypospadias. The follow-up periods ranged from 33-75 months, with an average of 52 months. The duration of surgery, the catheter indwelling period, and the postoperative complications of each patient were analyzed. The median age of the patients at the time of surgery was 3 years and 8 months. The length of surgery for OUPF II ranged from 150-230 min (average 186 min), and from 190-365 min (average 267 min) for OUPF IV. Postoperative complications were confirmed in 3 of the 18 patients (16.6%). Two patients had fistulas, and one had a meatal regression. The fistulas were successfully closed by the simple multilayered closure method. After adopting DuoDerm dressings instead of elastic bandages for protection of the wound, no fistulization occurred. DuoDerm dressings are useful in the healing of wounds without complications. To date, the longest follow-up period has been 75 months, and during that time there have been no late complications such as urethral stenosis or penile curvature. OUPF is a useful method in the treatment of hypospadias with a low incidence of early and late complications.</p> |
Keywords | hypospadias one-stageure throplasty OUPF DuoDerm dressings |
Amo Type | Article |
Published Date | 2005-04 |
Publication Title | Acta Medica Okayama |
Volume | volume59 |
Issue | issue2 |
Publisher | Okayama University Medical School |
Start Page | 45 |
End Page | 48 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | 英語 |
File Version | publisher |
Refereed | True |
PubMed ID | 16049554 |
Web of Science KeyUT | 000228590000002 |
JaLCDOI | 10.18926/AMO/48076 |
---|---|
FullText URL | 66_1_7.pdf |
Author | Kawauchi, Keiichiro| Watanabe, Masami| Kaku, Haruki| Huang, Peng| Sasaki, Kasumi| Sakaguchi, Masakiyo| Ochiai, Kazuhiko| Huh, Nam-ho| Nasu, Yasutomo| Kumon, Hiromi| |
Abstract | The preclinical safety and therapeutic efficacy of adenoviral vectors that express the REIC/Dkk-3 tumor suppressor gene (Ad-REIC) was examined for use in prostate cancer gene therapy. The Ad-human (h) and mouse (m) REIC were previously demonstrated to induce strong anti-cancer effects in vitro and in vivo, and we herein report the results of two in vivo studies. First, intra-tumor Ad-hREIC administration was examined for toxicity and therapeutic effects in a subcutaneous tumor model using the PC3 prostate cancer cell line. Second, intra-prostatic Ad-mREIC administration was tested for toxicity in normal mice. The whole-body and spleen weights, hematological and serum chemistry parameters, and histological evaluation of tissues from throughout the body were analyzed. Both experiments indicated that there was no significant difference in the examined parameters between the Ad-REIC-treated group and the control (PBS- or Ad-LacZ-treated) group. In the in vitro analysis using PC3 cells, a significant apoptotic effect was observed after Ad-hREIC treatment. Confirming this observation, the robust anti-tumor efficacy of Ad-hREIC was demonstrated in the in vivo subcutaneous prostate cancer model. Based on the results of these preclinical experiments, we consider the adenovirus-mediated REIC/Dkk-3 in situ gene therapy to be safe and useful for the clinical treatment of prostate cancer. |
Keywords | REIC Dickkopf-3 gene therapy prostate cancer preclinical study |
Amo Type | Original Article |
Published Date | 2012-02 |
Publication Title | Acta Medica Okayama |
Volume | volume66 |
Issue | issue1 |
Publisher | Okayama University Medical School |
Start Page | 7 |
End Page | 16 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | 英語 |
Copyright Holders | CopyrightⒸ 2012 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 22358134 |
Web of Science KeyUT | 000300800700002 |
Author | Huang, P| Kaku, H| Chen, J| Kashiwakura, Y| Saika, T| Nasu, Y| Urata, Y| Fujiwara, T| Watanabe, M| Kumon, H| |
---|---|
Published Date | 2010-07 |
Publication Title | Cancer Gene Therapy |
Volume | volume17 |
Issue | issue7 |
Content Type | Journal Article |
Author | Ochiai, Kazuhiko| Watanabe, Masami| Ueki, Hideo| Huang, Peng| Fujii, Yasuyuki| Nasu, Yasutomo| Noguchi, Hirofumi| Hirata, Takeshi| Sakaguchi, Masakiyo| Huh, Nam-ho| Kashiwakura, Yuji| Kaku, Haruki| Kumon, Hiromi| |
---|---|
Published Date | 2011-08-26 |
Publication Title | Biochemical and Biophysical Research Communications |
Volume | volume412 |
Issue | issue2 |
Content Type | Journal Article |
JaLCDOI | 10.18926/AMO/52144 |
---|---|
FullText URL | 68_1_47.pdf |
Author | Ishikawa, Tsutomu| Araki, Motoo| Hirata, Takeshi| Watanabe, Masami| Ebara, Shin| Watanabe, Toyohiko| Nasu, Yasutomo| Kumon, Hiromi| |
Abstract | We report 3 patients with the rare complication of an indwelling urethral catheter misdirected into the ureter. This is the largest series to date. Patients were referred to us for a variety of reasons following exchange of their chronic indwelling urinary catheters. CT in all cases demonstrated the urinary catheters residing in the left ureter. The ages of the patients were 37, 67 and 81 years old. All patients suffered from neurogenic bladder. Two patients were female, one was male, and 2 of the 3 had a sensory disorder inhibiting their pain response. The catheters were replaced with open-end Foley catheters. Extensive follow-up CT scans were obtained in one case, demonstrating improvement of hydronephrosis and no evidence of ureteral stenosis. Cystoscopy in this patient demonstrated normally positioned and functioning ureteral orifices. Although the placement of an indwelling urethral catheter is a comparatively safe procedure, one must keep in mind that this complication can occur, particularly in female patients with neurogenic bladder. CT without contrast is a noninvasive, definitive diagnostic tool. |
Keywords | complication indwelling urethral catheter imaging computed tomography ureter |
Amo Type | Case Report |
Published Date | 2014-02 |
Publication Title | Acta Medica Okayama |
Volume | volume68 |
Issue | issue1 |
Publisher | Okayama University Medical School |
Start Page | 47 |
End Page | 51 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | 英語 |
Copyright Holders | CopyrightⒸ 2014 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 24553489 |
Web of Science KeyUT | 000331592800008 |
JaLCDOI | 10.18926/AMO/54414 |
---|---|
FullText URL | 70_3_159.pdf |
Author | Yoshioka, Takashi| Otsuki, Hideo| Uehara, Shinya| Shimizu, Toshihiro| Murao, Wataru| Fujio, Koji| Fujio, Kei| Wada, Koichiro| Araki, Motoo| Nasu, Yasutomo| |
Abstract | Upper urinary tract calculi are common; however, there is no recommended treatment selection for elderly patients. Ureteroscopic holmium laser lithotripsy (URS lithotripsy) is minimally invasive, and it provides a high stone-free rate (SFR) treatment for upper urinary tract calculi. Here, we retrospectively evaluated the surgical outcomes of URS lithotripsy after dividing the 189 cases into 3 groups by patient age: the ʻ<65 groupʼ (<65 years old, n=108), the ʻ65-74 groupʼ (65-74 years old, n=42), and the ʻ 75 groupʼ ( 75 years old, n=39). The patientsʼ characteristics, stone status, and perioperative outcomes were assessed. The 65-74 group and the 75 group had a significantly higher prevalence of hypertension compared to the<65 group. Compared to the<65 group, the 65-74 group had a significantly higher prevalence of hyperlipidemia, and the 75 group had significantly higher the American Society of Anesthesiologists (ASA) scores. Despite these preoperative risk factors, SFR and postoperative pyelonephritis in the 65-74 group and the 75 group were similar to those of the<65 group. In conclusion, URS lithotripsy is the preferred treatment for upper urinary tract calculi, even for elderly patients who have multiple preoperative risk factors. |
Keywords | upper urinary tract calculi ureteroscopy (URS) holmium laser lithotripsy elderly patients stone-free rate (SFR) |
Amo Type | Original Article |
Published Date | 2016-06 |
Publication Title | Acta Medica Okayama |
Volume | volume70 |
Issue | issue3 |
Publisher | Okayama University Medical School |
Start Page | 159 |
End Page | 166 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | 英語 |
Copyright Holders | CopyrightⒸ 2016 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 27339204 |
Web of Science KeyUT | 000379406100002 |
JaLCDOI | 10.18926/AMO/56871 |
---|---|
FullText URL | 73_3_269.pdf |
Author | Tsuboi, Ichiro| Araki, Motoo| Fujiwara, Hiroyasu| Iguchi, Toshihiro| Hiraki, Takao| Arichi, Naoko| Kawamura, Kasumi| Maruyama, Yuki| Mitsui, Yosuke| Sadahira, Takuya| Kubota, Risa| Nishimura, Shingo| Sako, Tomoko| Takamoto, Atsushi| Wada, Koichiro| Kobayashi, Yasuyuki| Watanabe, Toyohiko| Yanai, Hiroyuki| Kitagawa, Masashi| Tanabe, Katsuyuki| Sugiyama, Hitoshi| Wada, Jun| Shiina, Hiroaki| Kanazawa, Susumu| Nasu, Yasutomo| |
Abstract | Nephron-sparing treatment should be offered whenever possible to avoid dialysis in allograph cases. Cryoablation is a new treatment option for treating small-sized renal cell cancer (RCCs). We report a case of RCC arising in a kidney allograft treated by cryoablation. To our knowledge, this is the first case in Asia of RCC in a renal allograft treated using cryoablation. Contrast-enhanced CT-guided percutaneous renal needle biopsy and cryoablation were used to identify the RCC, which could not be identified by other techniques. The postoperative course was uneventful. Contrast-enhanced CT also showed no recurrence or metastases at the 6-month follow-up. |
Keywords | cryoablation partial nephrectomy renal cell carcinoma renal allograft renal transplantation |
Amo Type | Case Report |
Published Date | 2019-06 |
Publication Title | Acta Medica Okayama |
Volume | volume73 |
Issue | issue3 |
Publisher | Okayama University Medical School |
Start Page | 269 |
End Page | 272 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | 英語 |
Copyright Holders | CopyrightⒸ 2019 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 31235976 |
JaLCDOI | 10.18926/AMO/30939 |
---|---|
FullText URL | fulltext.pdf |
Author | Kobayashi, Yasuyuki| Saika, Takashi| Manabe, Daisuke| Nasu, Yasutomo| Kumon, Hiromi| |
Abstract | <p>The purpose of this study is to compare the performance of laparoscopic partial nephrectomy (LPN) with and without clamping of the renal artery and to evaluate the impact of clamping on postoperative renal function. A total of 20 patients underwent LPN, 13 without and 7 with clamping of the renal artery. The 2 groups were compared with respect to complications, blood loss, operative time, mean tumor size, and incidence of positive margins. Renal function was evaluated by pre- and postoperative renal scintigraphy using <sup>99m</sup>Technetium-mercaptoacetyltriglycine (<sup>99m</sup>Tc-MAG3). Intraoperative blood loss was significantly higher in the group without clamping than in the group with clamping (p0.04). In the group with clamping, the median warm ischemic time was 35min (range 25-40min). The serum creatinine values and the renal scintigraphy showed no influence on postoperative renal function with or without clamping. In the group without clamping, 2 cases were showed positive surgical margins. The procedure performed with clamping of the renal artery is superior to the procedure performed without clamping as it provides the advantages of controlling hemorrhaging without injury to renal function and prolonging the surgical time and allowing for more accurate resection of renal tumors.</p> |
Keywords | laparoscopic partial nephrectomy <sup>99m</sup>Tc-MAG3 renal function |
Amo Type | Original Article |
Published Date | 2008-08 |
Publication Title | Acta Medica Okayama |
Volume | volume62 |
Issue | issue4 |
Publisher | Okayama University Medical School |
Start Page | 269 |
End Page | 273 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | 英語 |
File Version | publisher |
Refereed | True |
PubMed ID | 18766210 |
Web of Science KeyUT | 000258680900007 |
JaLCDOI | 10.18926/AMO/30950 |
---|---|
FullText URL | fulltext.pdf |
Author | Saika, Takashi| Kobayashi, Yasuyuki| Watanabe, Toyohiko| Manabe, Daisuke| Ebara, Shin| Uehara, Shinya| Nasu, Yasutomo| Kumon, Hiromi| |
Abstract | <p>To evaluate morbidity in Hybrid Radical Prostatectomy (HRP, hybridized laparoscopic and open retropubic radical prostatectomy). The operative and pathological outcomes obtained in 25 consecutive patients who underwent HRP were reviewed. The median operating time was 220min, median blood loss was 550ml, and no patient required an allogenic blood transfusion. No severe postoperative complications were observed. The surgical margin was positive in 12% of all patients, and in 1 patient with pT2 or less (4.5%). These results indicate that HRP is safe and may be able to combine the benefits of both laparoscopic and open procedures.</p> |
Keywords | prostate cancer radical prostatectomy hybrid surgery morbidity positive surgical margin |
Amo Type | Original Article |
Published Date | 2008-12 |
Publication Title | Acta Medica Okayama |
Volume | volume62 |
Issue | issue6 |
Publisher | Okayama University Medical School |
Start Page | 379 |
End Page | 384 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | 英語 |
File Version | publisher |
Refereed | True |
Web of Science KeyUT | 000262025000004 |
JaLCDOI | 10.18926/AMO/30986 |
---|---|
FullText URL | fulltext.pdf |
Author | Ebara, Shin| Katayama, Yoshihisa| Tanimoto, Ryuta| Edamura, Kohei| Nose, Hiroyuki| Manabe, Daisuke| Kobayashi, Tomoko| Kobayashi, Yasuyuki| Kobuke, Makoto| Takemoto, Mitsuhiro| Saika, Takeshi| Nasu, Yasutomo| Kanazawa, Susumu| Kumon, Hiromi| |
Abstract | <p>From January 2004 to March 2007, 308 patients with clinically localized prostate cancer were treated using iodine-125 (125I) seed implantation (permanent brachytherapy) at Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. We evaluated the treatment’s effi cacy and morbidity in 300 prostate cancer patients who were followed up for more than 1 month after brachytherapy. Based on the National Comprehensive Cancer Network (NCCN) guidelines, patients with a prostate volume of less than 40 ml in transrectal ultrasound imaging were classifi ed as low or intermediate risk. The median patient age was 67 years (range 50 to 79 years), the median prostate-specific antigen (PSA) value before biopsy was 6.95 ng/ml (range 1.13 to 24.7 ng/ml), and the median prostate volume was 24.33 ml (range 9.3 to 41.76 ml). The median follow-up was 18 months (range 1 to 36 months) and the PSA levels decreased in almost all patients after brachytherapy. Although 194 of 300 patients (64.7%) complained of diffi culty in urination, pollakisuria/urgency, miction pain, and/or urinary incontinence, all of which might be associated with radiation prostatitis during the fi rst month after brachytherapy, these symptoms gradually improved. 125I seed implantation brachytherapy is safe and eff ective for localized prostate cancer within short-term follow up.</p> |
Keywords | localized prostate cancer brachytherapy prostate specific antigen urinary morbidity |
Amo Type | Original Article |
Published Date | 2008-02 |
Publication Title | Acta Medica Okayama |
Volume | volume62 |
Issue | issue1 |
Publisher | Okayama University Medical School |
Start Page | 9 |
End Page | 13 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | 英語 |
File Version | publisher |
Refereed | True |
PubMed ID | 3558 |
Web of Science KeyUT | 000255297600011 |
JaLCDOI | 10.18926/AMO/32862 |
---|---|
FullText URL | 64_1_27.pdf |
Author | Kobayashi, Yasuyuki| Saika, Takashi| Manabe, Daisuke| Nasu, Yasutomo| Kumon, Hiromi| |
Abstract | We analyzed the prognostic factors influencing survival after surgeries for upper urinary tract urothelial carcinoma (UUT-UC) with longer follow-up periods than in previous studies. Between January 2000 and December 2004, 386 patients underwent nephroureterectomy for UUT-UC. The data for the 221 patients with UUT-UC were retrospectively reviewed. Nine variables were evaluated for association with the survival outcomes of cause-specific survival. The prognostic significance was tested univariately with the log-rank test. The simultaneous effects of multiple prognostic factors were estimated by multiple regression analysis using the Cox proportional hazards model. The median follow-up was 38.4 months. The 5-year over all survival was 62.3%. Significant prognostic factors for disease-specific survival rate on univariate analysis were pathological stage (p0.0001), tumor grade (p0.0324), and venous invasion (p0.0001). Multivariate analysis revealed that only venous invasion was significant for disease-specific survival rate (p0.0205). Venous invasion was the only independent prognostic factor in pathologically localized UUT-UC. |
Keywords | nephroureterectomy transitional cell carcinoma upper urinary tract |
Amo Type | Original Article |
Note | <a href="http://ousar.lib.okayama-u.ac.jp/amo/vol65/iss2/11">Erratum with Corrected and Republished Article</a>| |
Published Date | 2010-02 |
Publication Title | Acta Medica Okayama |
Volume | volume64 |
Issue | issue1 |
Publisher | Okayama University Medical School |
Start Page | 27 |
End Page | 31 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | 英語 |
Copyright Holders | CopyrightⒸ 2010 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 20200581 |
Web of Science KeyUT | 000274868300004 |
JaLCDOI | 10.18926/AMO/32878 |
---|---|
FullText URL | fulltext.pdf |
Author | Ebara, Shin| Manabe, Daisuke| Kobayashi, Yasuyuki| Tanimoto, Ryuta| Saika, Takashi| Nasu, Yasutomo| Saito, Shirou| Satoh, Takefumi| Miki, Kenta| Hashine, Katsuyoshi| Kumon, Hiromi| |
Abstract | <p>From September 2003 to December 2005, 188 patients who visited our hospital and allied institutions for the purpose of prostate brachytherapy were administrated hormonal therapy for volume reductions before brachytherapy. The pretreatment and posttreatment of prostate volume using a transrectal ultrasound volumetric study and the types and duration of hormonal therapy were analyzed. We administered 91 patients with Luteinizing hormone-releasing hormone (LH-RH) agonist, 49 patients with anti-androgen (bicaltamide/flutamide), and 48 patients with maximum androgen blockade (MAB). The duration of the hormonal therapy was 1-3 months for 49 patients, 4-6 months for 59 patients, 7-9 months for 40 patients, 10-12 months for 32 patients, and over 13 months for 8 patients. Before the initiation of hormonal therapy, the mean prostate volume was 35.12 ml (11.04-78.71 ml), and the average of prostate volume before and after hormonal therapy was 36.79 ml and 24.79 ml, respectively (a 32.4% reduction). The prostate volume reduction rate was 32.0% for the LH-RH agonist only, 18.1% for the anti-androgen only and 41.2% for the MAB. No statistically significant difference was observed for the duration of hormonal therapy between 3 groups. A three-month course of the neoadjuvant LH-RH agonist indicated a sufficient volume reduction effectiveness for a large prostate volume.</p> |
Keywords | androgen deprivation therapy brachytherapy localized prostate cancer prostate volume reduction |
Amo Type | Original Article |
Published Date | 2007-12 |
Publication Title | Acta Medica Okayama |
Volume | volume61 |
Issue | issue6 |
Publisher | Okayama University Medical School |
Start Page | 335 |
End Page | 340 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | 英語 |
File Version | publisher |
Refereed | True |
PubMed ID | 18183078 |
Web of Science KeyUT | 000251943800004 |
JaLCDOI | 10.18926/AMO/45274 |
---|---|
FullText URL | 65_2_143.pdf |
Author | Kobayashi, Yasuyuki| Saika, Takashi| Manabe, Daisuke| Nasu, Yasutomo| Kumon, Hiromi| |
Abstract | We analyzed the prognostic factors influencing survival after surgeries for upper urinary tract urothelial carcinoma (UUT-UC) with longer follow-up periods than in previous studies. Between January 2000 and December 2004, 386 patients underwent nephroureterectomy for UUT-UC. The data for the 221 patients with UUT-UC were retrospectively reviewed. Nine variables were evaluated for association with the survival outcomes of cause-specific survival. The prognostic significance was tested univariately with the log-rank test. The simultaneous effects of multiple prognostic factors were estimated by multiple regression analysis using the Cox proportional hazards model. The median follow-up was 38.4 months. The 5-year over all survival was 62.3%. Significant prognostic factors for disease-specific survival rate on univariate analysis were pathological stage (p0.0001), tumor grade (p0.0324), and venous invasion (p0.0001). Multivariate analysis revealed that only venous invasion was significant for disease-specific survival rate (p0.0205). Venous invasion was the only independent prognostic factor in pathologically localized UUT-UC. |
Keywords | nephroureterectomy transitional cell carcinoma upper urinary tract |
Amo Type | Corrected and Republished Article |
Published Date | 2011-04 |
Publication Title | Acta Medica Okayama |
Volume | volume65 |
Issue | issue2 |
Publisher | Okayama University Medical School |
Start Page | 143 |
End Page | 149 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | 英語 |
Copyright Holders | CopyrightⒸ 2011 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 20200581 |
Web of Science KeyUT | 000289818800011 |
Author | Bekku, Kensuke| Saika, Takashi| Kobayashi, Yasuyuki| Kioshimoto, Ryo| Kanbara, Taiki| Nasu, Yasutomo| Kumon, Hiromi| |
---|---|
Published Date | 2013-02 |
Publication Title | International Journal of Clinical Oncology |
Volume | volume18 |
Issue | issue1 |
Content Type | Journal Article |
JaLCDOI | 10.18926/AMO/54982 |
---|---|
FullText URL | 71_2_135.pdf |
Author | Mori, Akihiro| Watanabe, Masami| Sadahira, Takuya| Kobayashi, Yasuyuki| Ariyoshi, Yuichi| Ueki, Hideo| Wada, Koichiro| Ochiai, Kazuhiko| Li, Shun-Ai| Nasu, Yasutomo| |
Abstract | The cluster of differentiation 147 (CD147), also known as EMMPRIN, is a key molecule that promotes cancer progression. We previously developed an adenoviral vector encoding a tumor suppressor REIC/Dkk-3 gene (Ad-REIC) for cancer gene therapy. The therapeutic effects are based on suppressing the growth of cancer cells, but, the underlying molecular mechanism has not been fully clarified. To elucidate this mechanism, we investigated the effects of Ad-REIC on the expression of CD147 in LNCaP prostate cancer cells. Western blotting revealed that the expression of CD147 was significantly suppressed by Ad-REIC. Ad-REIC also suppressed the cell growth of LNCaP cells. Since other researchers have demonstrated that phosphorylated mitogen-activated protein kinases (MAPKs) and c-Myc protein positively regulate the expression of CD147, we investigated the correlation between the CD147 level and the activation of MAPK and c-Myc expression. Unexpectedly, no positive correlation was observed between CD147 and its possible regulators, suggesting that another signaling pathway was involved in the downregulation of CD147. This is the first study to show the downregulation of CD147 by Ad-REIC in prostate cancer cells. At least some of the therapeutic effects of Ad-REIC may be due to the downregulation of the cancer-progression factor, CD147. |
Keywords | prostate cancer REIC/Dkk-3 CD147 cell growth p38 MAP kinase |
Amo Type | Original Article |
Published Date | 2017-04 |
Publication Title | Acta Medica Okayama |
Volume | volume71 |
Issue | issue2 |
Publisher | Okayama University Medical School |
Start Page | 135 |
End Page | 142 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | 英語 |
Copyright Holders | CopyrightⒸ 2017 by Okayama University Medical School |
File Version | publisher |
Refereed | True |
PubMed ID | 28420895 |
FullText URL | fulltext.pdf |
---|---|
Author | Xu, Naijin| Lin, Wenfeng| Sun, Jingkai| Sadahira, Takuya| Xu, Abai| Watanabe, Masami| Guo, Kai| Araki, Motoo| Li, Gonghui| Liu, Chunxiao| Nasu, Yasutomo| Huang, Peng| |
Keywords | Nitroxoline Bladder cancer EMT immunotherapy preclinical model |
Published Date | 2020-09-23 |
Publication Title | Journal of Cancer |
Volume | volume11 |
Issue | issue22 |
Publisher | Ivyspring International Publisher |
Start Page | 6633 |
End Page | 6641 |
ISSN | 1837-9664 |
Content Type | Journal Article |
language | 英語 |
OAI-PMH Set | 岡山大学 |
Copyright Holders | © The author(s). |
File Version | publisher |
PubMed ID | 33046984 |
DOI | 10.7150/jca.47025 |
Web of Science KeyUT | 000575099000017 |
Related Url | isVersionOf https://doi.org/10.7150/jca.47025 |